Autres langues

30/07 Spineway : H1 2026 results
30/07 Spineway SA Reports Earnings Results for the Half Year Ended June 30, 2026
30/07 Spineway SA announced that it expects to receive ?1.5 million in funding
30/04 Spineway : First-quarter 2026 revenue
30/04 Spineway SA Reports Unaudited Consolidated Revenue Results for the First Quarter of 2026
07/04 SPINEWAY : Minutes of the General Meeting of April 2, 2026
17/02 Spineway : 2025 annual results
17/02 Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2025
13/01 Spineway Sa Announces Revenue Results for Second Half and Full Year 2025
13/01 SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sales in Q4 2025 (+34%)
14/10/25 Spineway : Revenue growth in the third quarter
14/10/25 Spineway SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2025
30/07/25 Spineway : H1 2025 results - Continued improvement in results and financial position
30/07/25 Spineway SA Reports Earnings Results for the Half Year Ended June 30, 2025
03/07/25 Spineway : GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses
06/06/25 Spineway : Minutes of the General Meeting of June 4, 2025
19/05/25 Spineway : Combined General Meeting of June 4, 2025 - Availability of preparatory documents
16/04/25 Spineway : First-quarter 2025 revenue of €2.8 million
24/03/25 Spineway : Consolidated 2024 annual results - Operating income close to breakeven
24/03/25 Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2024
27/02/25 Spineway marks its return to Arab Health 2025 with new distribution agreements
22/01/25 Spineway : 2024 revenue of €12 million - 14% growth compared with 2023
19/12/24 Spineway Secures Approvals in Vietnam for Certain Product Lines
18/12/24 Spineway wins new approvals in Vietnam and registers initial orders
18/12/24 Spineway Wins New Approvals in Vietnam and Registers Initial Orders
Aucun résultat pour cette recherche